131 related articles for article (PubMed ID: 20488734)
1. Biomarkers of cartilage turnover. Part 2: Non-collagenous markers.
Garvican ER; Vaughan-Thomas A; Clegg PD; Innes JF
Vet J; 2010 Jul; 185(1):43-9. PubMed ID: 20488734
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis.
Garvican ER; Vaughan-Thomas A; Innes JF; Clegg PD
Vet J; 2010 Jul; 185(1):36-42. PubMed ID: 20488735
[TBL] [Abstract][Full Text] [Related]
3. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis.
Ratcliffe A; Billingham ME; Saed-Nejad F; Muir H; Hardingham TE
J Orthop Res; 1992 May; 10(3):350-8. PubMed ID: 1569498
[TBL] [Abstract][Full Text] [Related]
4. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
5. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
6. Anatomical localization of cartilage degradation markers in a surgically induced rat osteoarthritis model.
Wancket LM; Baragi V; Bove S; Kilgore K; Korytko PJ; Guzman RE
Toxicol Pathol; 2005; 33(4):484-9. PubMed ID: 16036866
[TBL] [Abstract][Full Text] [Related]
7. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
Céleste C; Ionescu M; Robin Poole A; Laverty S
J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
[TBL] [Abstract][Full Text] [Related]
8. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
9. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
10. Effects of shear stress on articular chondrocyte metabolism.
Lane Smith R; Trindade MC; Ikenoue T; Mohtai M; Das P; Carter DR; Goodman SB; Schurman DJ
Biorheology; 2000; 37(1-2):95-107. PubMed ID: 10912182
[TBL] [Abstract][Full Text] [Related]
11. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9.
Cucchiarini M; Thurn T; Weimer A; Kohn D; Terwilliger EF; Madry H
Arthritis Rheum; 2007 Jan; 56(1):158-67. PubMed ID: 17195218
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
Brandt KD; Slowman-Kovacs S
Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
[TBL] [Abstract][Full Text] [Related]
14. A material decoy of biological media based on chitosan physical hydrogels: application to cartilage tissue engineering.
Montembault A; Tahiri K; Korwin-Zmijowska C; Chevalier X; Corvol MT; Domard A
Biochimie; 2006 May; 88(5):551-64. PubMed ID: 16626850
[TBL] [Abstract][Full Text] [Related]
15. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
16. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
17. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Biomarkers for cartilage matrix turnover and destruction in joint diseases].
Kojima T
Clin Calcium; 2006 Jun; 16(6):1009-15. PubMed ID: 16751698
[TBL] [Abstract][Full Text] [Related]
18. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
[TBL] [Abstract][Full Text] [Related]
19. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions.
Malemud CJ; Martel-Pelletier J; Pelletier JP
J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934
[TBL] [Abstract][Full Text] [Related]
20. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
